LGALS1 and neoplasm: Silencing galectin-1 suppressed proliferation, motility, side population fraction, and tumorsphere formation <i>in vitro</i>, and impaired tumor initiation and growth <i>in vivo</i>, whereas overexpression enhanced these malignant phenotypes.